文献速递功能神经外科

伽玛刀治疗三叉神经痛初始疗效不良预测模型的开发与验证

Development and validation of a predictive model for poor initial outcomes after Gamma Knife radiosurgery for trigeminal neuralgia: a prognostic correlative analysis.
PubMed 文献 · J Neurosurg · 2025-05-30

本研究基于217例原发性三叉神经痛(PTN)患者,开发并验证了伽玛刀放射外科(GKRS)后初始疗效不良的预测模型,训练集和验证集AUC分别为0.85和0.88。高血糖、缺乏神经血管接触、卡马西平不敏感及非典型疼痛(TN2)是独立危险因素,同时具备TN2和卡马西平不敏感的患者初始疗效最差且复发风险增加。

要点

  • 该模型可基于临床和影像特征预测GKRS后初始疗效不良的概率。
  • 高血糖、无神经血管接触、卡马西平不敏感及TN2为独立危险因素。
  • TN2合并卡马西平不敏感者初始疗效最差且长期复发风险更高。

核心结论

  • 同时具有TN2和卡马西平不敏感的患者初始治疗结局最差且复发风险增加。
  • 该预测模型准确性高,可综合临床和影像特征识别初始疗效不良的高危患者。

研究设计与样本

  • 回顾性预后相关分析,共纳入217例接受GKRS的原发性三叉神经痛患者。
  • 患者分为训练集(n=167)和验证集(n=50),初始结局采用Barrow神经病学研究所疼痛强度量表评估。
  • 通过多因素回归开发预测模型,并采用重复抽样进行验证。

主要发现

  • 训练集和验证集的曲线下面积分别为0.85和0.88。
  • 校准曲线和决策曲线分析显示两个集均有显著临床获益。
  • 初始疗效不良的独立危险因素包括高血糖、缺乏神经血管接触、卡马西平不敏感及非典型疼痛(TN2)。
  • 卡马西平不敏感与TN2中度相关,并可预测长期疼痛复发。
  • 同时具有TN2和卡马西平不敏感的患者与其他亚组相比初始结局显著更差(校正p=0.0125)。

临床怎么用

  • 临床可利用该列线图计算多个变量,预测GKRS后初始疗效不良的概率。
  • 对具有高血糖、无神经血管接触、卡马西平不敏感或TN2特征的患者,应提前识别并加强管理预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The present study aimed to develop a reliable predictive model for identifying preoperative predictors of poor initial outcomes in patients with primary trigeminal neuralgia (PTN) treated with Gamma Knife radiosurgery (GKRS) and further elucidate the clinical significance of these predictors in initial outcomes and long-term pain recurrence. METHODS: A total of 217 PTN patients were divided into a training set (n = 167) and a validation set (n = 50). The initial outcomes of GKRS treatment were assessed based on the Barrow Neurological Institute pain intensity scale. A predictive model was developed through multivariate regression and validated with repeated sampling. The differences in predictors of long-term pain recurrence were assessed using Kaplan-Meier analysis. The association between predictors was tested using chi-square tests, and subgroup analyses were performed to compare initial outcomes and long-term pain recurrence between two clinically significant correlates. RESULTS: The training and validation sets showed areas under the curve of 0.85 and 0.88, respectively. Calibration curves and decision curve analysis indicated significant clinical benefits in both sets. Independent risk factors for poor initial outcomes included hyperglycemia, absence of neurovascular contact, carbamazepine insensitivity, and atypical pain (trigeminal neuralgia type 2 [TN2]). Carbamazepine insensitivity was moderately associated with TN2 and predicted long-term pain recurrence. Patients with both phenotypes had significantly worse initial outcomes compared with other subgroups (adjusted p = 0.0125). CONCLUSIONS: Patients with both TN2 and carbamazepine insensitivity have the poorest initial treatment outcomes and face an increased risk of recurrence. Furthermore, this predictive model is highly accurate and useful, offering a comprehensive method of identifying PTN patients likely to experience poor initial outcomes based on clinical characteristics and imaging perspectives. The authors believe that the nomogram presented in this model enables clinicians to calculate multiple variables and predict the probability of adverse events.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wang S, Chen G, Xie J, et al. Development and validation of a predictive model for poor initial outcomes after Gamma Knife radiosurgery for trigeminal neuralgia: a prognostic correlative analysis. J Neurosurg. 2025. PMID: 40446349. doi:10.3171/2025.2.JNS242655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。